Gong, X., Li Shao., Yi-Min Fu., Yong Z. 2015. Effect of Olmesartan on Endothelial
Progenitor Cell Mobilization and Function in Carotid Atherosclerosis. Medical
Science Monitor, 21: 1189-1193.
Gorostidi, Manuel. 2015. Effect of Olmesartan-Based Therapies on Theraputic Indicators
Obtained Through Out-of-Office Blood Pressure. Cardiology and Therapy, 4 (Suppl
1): 19-30.
Ikawati, Zullies. 2008. Pengantar Farmakologi Molekuler. Yogyakarta : UGM Press.
Mohan J.C., Rishi J., Vijay C., and Amit B. 2015. Short Term Safety and Tolerability of a
Fixed Dose Combination of Olmesartan, Amlodipine, and Hydrochlorothiazide.
Journal of Clinical and Diagnostic Research, 9 (8): OC10-OC13.
Pepeliascov, V., Kleber D.M.G., Dones C.J.J., Helen D.L., and Felipe D.L.J. 2015. AT1
Receptor Antagonist: Pharmacological Treatment of Hypertention in Brazil.
Biomedical Science and Engineering, 3 (2): 41-45.
Rishi, A., and Katherine G. 2015. Unusual Severe Side Effect of a Commonly Used Drug.
The Journal of Clinical Hypertension, 18 (4): 363.